Daisho Microline Sees Major Stake Transfer to AI-Linked Shareholder

Daisho Microline Holdings Limited ( (HK:0567) ) just unveiled an update.

Daisho Microline Holdings Limited has seen a major reshuffle in its shareholder base following the sale of 280,000,000 shares, or about 17.36% of its issued capital, by substantial shareholder Spring Global Enterprises Limited to Jsmart Technologies Limited. The transaction removes Spring Global as a shareholder, while Jsmart, controlled by AI entrepreneur Dr. Sun Jing’an and his spouse, becomes a substantial shareholder, deepening ties with existing AI healthcare ventures.

The board noted that the transfer is not expected to have any material adverse impact on the Group’s operations, suggesting business continuity despite the ownership change. With Jsmart already linked to Daisho Microline through a joint venture in AI and intelligent robots for healthcare, the new stake may further align strategic interests, though the company has advised investors and shareholders to remain cautious when trading its securities.

The most recent analyst rating on (HK:0567) stock is a Hold with a HK$0.46 price target. To see the full list of analyst forecasts on Daisho Microline Holdings Limited stock, see the HK:0567 Stock Forecast page.

More about Daisho Microline Holdings Limited

Daisho Microline Holdings Limited, incorporated in Bermuda and listed in Hong Kong, operates through a group structure that includes a majority-owned joint venture in embodied intelligence. Through this JV, the Group focuses on commercial applications of artificial intelligence and intelligent robots for medical treatment, rehabilitation and elderly care, positioning it in the healthcare-related AI technology space.

Average Trading Volume: 5,993,391

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$742.1M

Learn more about 0567 stock on TipRanks’ Stock Analysis page.